Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver



Status:Archived
Conditions:Breast Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2007
End Date:December 2012

Use our guide to learn which trials are right for you!

A Phase II Feasibility Study to Assess the Use of SIR-Sphere in Patients With Breast Cancer Who Have Chemotherapy-Resistant Disease in the Liver


The purpose of this study to study whether or not the use of direct radiation therapy with
Y-90 microspheres (SIR-Spheres) has any effect on treated liver with respect to tumor
response in breast cancer patients.

Criteria:

- Breast cancer

- Clinical evidence of metastatic disease in the liver

- Performance status (0-2)

- Not pregnant

- Laboratory values received after any prior chemotherapy

- Normal Pt/PTT

- recovered from any chemotherapy side-effects

- No prior radiation therapy to the liver

- No other MAJOR site of cancer such as lungs or brain

- No uncontrolled infections

- a candidate for surgical resection or ablation therapy


Patient must pass an MAA angiography study to detect abnormal shunting of the vessels to the
lungs and stomach. Shunting of the radiation seeds to these areas, if an abnormality exists
would be harmful.


We found this trial at
1
site
?
mi
from
Tampa, FL
Click here to add this to my saved trials